Atrion Stock (NASDAQ: ATRI) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 18.937K |
Day Range | - - - |
52 Wk Range | 274.980 - 643.480 |
Market Cap | $713.244M |
P/E Ratio | 38.493 |
Dividend Yield | 2.070% |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 10.26% |
Days to Cover | 4.15 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Atrion (NASDAQ: ATRI) through any online brokerage.
Other companies in Atrion’s space includes: Solventum (NYSE:SOLV), TELA Bio (NASDAQ:TELA), RxSight (NASDAQ:RXST), Embecta (NASDAQ:EMBC) and Align Tech (NASDAQ:ALGN).
The latest price target for Atrion (NASDAQ: ATRI) was reported by BWS Financial on Monday, April 25, 2016. The analyst firm set a price target for 300.00 expecting ATRI to fall to within 12 months (a possible -25.98% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Atrion (NASDAQ: ATRI) is $405.29 last updated April 23, 2024 at 4:02 PM EDT.
A quarterly cash dividend of $2.20 per share of Class A Common Stock. The quarterly cash dividend was payable on March 29, 2024 to stockholders of record on March 14, 2024.
Atrion’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Atrion.
Atrion is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.